JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 20 No. 9 973-976
© 1979 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tisljar, U.
Right arrow Articles by Stöcklin, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tisljar, U.
Right arrow Articles by Stöcklin, G.

Accumulation of Radioiodinated L-a-Methyltyrosine in Pancreas of Mice: Concise Communication

U. Tisljar, G. Kloster, F. Ritzl and G. Stöcklin

Institut für Chemie 1 (Nuklearchemie) der KFA Jülich GmbH, D-5170 Jülich, FRG
Klinik för Nuklearmedizin, D-5600 Wuppertal, FRG

Correspondence: For reprints contact: G. Stücklin, Institut för Chemie, der Kernforschungsanlage Julich GmbH, D-5170 Julich, FRG.

ABSTRACT

L-3-iodo-\ga-methyltyrosine, labeled with either I-131 or I-123, has a high pancreatic specificity in mice. A pancreas-to-liver ratio of 8.6 \+- 2.7 is observed during the first hour after i.v. injection. Accumulation is also prominent in the kidneys, but excretion of the radioagent is rapid, 50% of the activity being eliminated during 90 min. Compared with L-[75Se]selenomethionine, the compound currently used for pancreatic imaging, L-3-[123I] or [131I]iodo-\ga-methyltyrosine has a higher pancreas-to-liver ratio, a shorter physical half-life and biological half-time, and better decay characteristics.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1979 by the Society of Nuclear Medicine.